HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dior’s Got Spring Fever With Launches In Skin Care, Makeup, Fragrance

This article was originally published in The Rose Sheet

Executive Summary

Christian Dior Parfums will begin rolling out new skin care, cosmetics and fragrance products in March to the brand's tightened distribution network. The firm unveiled its spring launch plan at an event in New York City Jan. 22

You may also be interested in...



Christian Dior U.S. Turnaround Centered On Brand’s Fashion Heritage

The turnaround effort underway at Christian Dior Perfumes is aiming to drive sales of the LVMH division's fragrance and cosmetics business in the U.S. by reconnecting the brand to its fashion heritage, according to U.S. Cosmetics and Perfumes President Pamela Baxter

Christian Dior U.S. Turnaround Centered On Brand’s Fashion Heritage

The turnaround effort underway at Christian Dior Perfumes is aiming to drive sales of the LVMH division's fragrance and cosmetics business in the U.S. by reconnecting the brand to its fashion heritage, according to U.S. Cosmetics and Perfumes President Pamela Baxter

LVMH Perfumes & Cosmetics Operating Profit Up 10.6% In 2003

LVMH's Perfumes & Cosmetics business generated a 10.6% increase in operating income to reach $215.2 mil. (€1=$1.21) for 2003, largely on the strength of Christian Dior Parfums, the firm reported in a year-end earnings release March 3

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011840

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel